Pantoprazole Teva Teva Conseil (Pantoprazole Sodium)

Pantoprazole Sodium, the active ingredient in Pantoprazole Teva Teva Conseil, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazole Teva Teva Conseil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Pantoprazole Teva Teva Conseil is a proton pump inhibitor that acts on the gastric acid secretion pathway. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive esophagitis: accelerates mucosal healing and reduces further erosion. - Peptic ulcer disease: supports ulcer healing and prevents recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition.

Adverse reactions to pantoprazole are generally mild to moderate and vary in frequency.

Common Side Effects: - Headache: mild, transient headache reported by some patients. - Diarrhea: loose stools occurring during early treatment. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: severe diarrhea with abdominal pain. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Liver enzyme elevation: increased ALT/AST indicating hepatic stress. - Fracture risk: potential decrease in bone mineral density with long‑term use.

Before initiating therapy, consider patient‑specific factors and monitor appropriately. - Renal impairment: dose adjustment may be required in severe kidney disease. - Hepatic impairment: use with caution in patients with liver dysfunction. - Elderly patients: monitor for increased sensitivity to side effects. - Concomitant use of drugs requiring gastric acidity: assess potential reduced efficacy. - Pregnancy and lactation: evaluate risk‑benefit ratio before prescribing. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazole may affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): reduced absorption due to increased gastric pH. - HIV protease inhibitors (atazanavir, nelfinavir): markedly decreased plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation parameters. - Methotrexate: reduced renal clearance may raise serum levels. - Digoxin: slight increase in serum concentration; observe for toxicity signs. - Clopidogrel: potential reduction in antiplatelet effect; consider alternative therapy.